An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults

BACKGROUND: West Nile virus (WNV) is the most common mosquito-borne infection in the United States. HydroVax-001 WNV is a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) vaccine adjuvanted with aluminum hydroxide. METHODS: We performed a phase 1, randomized, placebo-controlled, doubl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Main Authors: Woods, Christopher W., Sanchez, Ana M., Swamy, Geeta K., McClain, Micah T., Harrington, Lynn, Freeman, Debra, Poore, Elizabeth A., Slifka, Dawn K., Poer DeRaad, Danae E., Amanna, Ian J., Slifka, Mark K., Cai, Shu, Shahamatdar, Venus, Wierzbicki, Michael R., Amegashie, Cyrille, Walter, Emmanuel B.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6640644/
https://ncbi.nlm.nih.gov/pubmed/30661836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.12.026
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares